Literature DB >> 24621673

N-acetylcysteine in COPD may be beneficial, but for whom?

Mario Cazzola1, Maria Gabriella Matera2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24621673     DOI： 10.1016/S2213-2600(13)70294-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

2.  Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives.

Authors:  Mario Cazzola; Paola Rogliani; Maria Gabriella Matera
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 3.  N-acetylcysteine in COPD: why, how, and when?

Authors:  Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2016-02-03

4.  Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019.

Authors:  Yuanfeng Zhang; Zheyi Wang; Yue Zhang; Hongxuan Tong; Yiling Zhang; Tao Lu
Journal:  Front Mol Biosci       Date:  2020-12-14

Review 5.  Positioning new pharmacotherapies for COPD.

Authors:  Igor Z Barjaktarevic; Anthony F Arredondo; Christopher B Cooper
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.